DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 3351--------------------------------------------------
       And now for orelabrutinib
       By: agate Date: July 16, 2021, 10:57 pm
       ---------------------------------------------------------
       Biogen is coming up with another MS drug.  From Clinical Trials
       Arena (July 16, 2021), "Biogen expands its MS pipeline portfolio
       with a promising new agent":
  HTML https://www.clinicaltrialsarena.com/comment/biogen-multiple-sclerosis-pipeline-portfolio/
       It's in a Phase 2 clinical trial at this point, according to
       Multiple Sclerosis News Today (July 14, 2021):
  HTML https://multiplesclerosisnewstoday.com/news-posts/2021/07/14/biogen-strikes-deal-innocare-orelabrutinib-potential-oral-ms-therapy-phase-2-trial/
       *****************************************************